GutFlora Omics Platform Announces Solutions for Gut Microbiota Related Mental Disorder

May 18, 2021

GutFlora Omics Platform belongs to Creative Proteomics. With more than 10 years of experience in providing advanced multi-omics services, GutFlora Omics Platform offers services and support to customers through comprehensive intestinal flora research solutions. The product manager announced with excitement that the company has developed research solutions for all kinds of gut microbiota related mental disorders such as anxiety, autism, bipolar disorders, chronic fatigue syndrome, depression, parkinson's disease, etc.


The gastrointestinal tract is the host of a variety of microorganisms, which plays a vital role in regulating and maintaining the homeostasis of the host. Intestinal flora is an important factor in regulating mental health, and there may be significant differences in the composition of the intestinal flora of the above-mentioned mental patients. Changes in the stability and diversity of the intestinal flora will affect the neural, immune and endocrine pathways, and may even induce the progression of various syndromes in different systems. Mental health has become an urgent issue of public concern.


“In recent years, the mutual adjustment between the intestinal flora and the host and its important impact on health have gradually been paid attention to. In particular, the discovery of the brain-gut-microbial axis and the continuous exploration of its functions have caused more research to focus on the neuromodulation of intestinal flora. Studies have shown that the intestinal flora is closely related to the occurrence and development of a variety of neuropsychiatric diseases, such as autism, Alzheimer's disease, drug addiction, stress-related disorders, and sleep disorders.” Said of Creative Proteomics.


“Creative Proteomics provides the most valid and state-of-the-art solutions to meet your needs. We can not only assist you in profiling the gut microbiota of arrays of varied individuals under multi-omics frames but researching the microbiota-gut-brain axis as an organic whole by discovering the signaling biomarkers, figuring out the pathways, interpreting the regulation mechanism, and finally, developing therapeutic schemes such as probiotics, prebiotics, fecal transplantation, and therapeutic targets and pathways.” He added.


Creative Proteomics is committed to providing the highest level of solutions for the research of intestinal flora, and will provide the most suitable strategy based on the samples provided by the customer and the purpose of the research. Its expertise covers a variety of genomics, including metagenomics, metatranscriptomics, metaproteomics and metabolomics. Coupled with a powerful bioinformatics platform and other practical tools and resources, Creative Proteomics guarantees that you will get the most comprehensive solution for intestinal flora research.


About GutFlora Omics Platform of Creative Proteomics

The GutFlora Omics platform, an important division of Creative Proteomics, is dedicated to solving complex problems in intestinal microbiology research through Multi-Omics Technologies. The GutFlora Omics platform can not only provide customers with multi-omics services and bioinformatics analysis, but also seek solutions based on these technologies on the basis of exploring diseases, drug development and many other aspects.